XSIRA PHARMACEUTICALS

What this means for you

This application is over — abandoned 07 Dec 2006. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number

78502735

Mark type

Stylized text

Filed

20 Oct 2004

Published for opposition

14 Mar 2006

Abandoned

07 Dec 2006

Attorney of record

Bassam N. Ibrahim

Goods and services

• Class 001 — Chemicals: CHEMICAL-RELATED PRODUCTS, NAMELY, CHEMICAL ADDITIVES FOR USE IN THE MANUFACTURE OF PHARMACEUTICALS AND THE MANUFACTURE OF MEDICAL DIAGNOSTIC ASSAYS FOR USE IN HIGH THROUGHPUT AND HIGH CONTENT SCREENING FOR CLINICAL AND MEDICAL LABORATORY USE
• Class 005 — Pharmaceuticals: FULL LINE OF PHARMACEUTICALS; MEDICAL DIAGNOSTIC ASSAYS FOR USE IN HIGH THROUGHPUT AND HIGH CONTENT SCREENING FOR CLINICAL AND MEDICAL LABORATORY USE
• Class 042 — Scientific and technological services: LICENSING OF PATENTED TECHNOLOGY IN THE PHARMACEUTICAL AND LIFE SCIENCES FIELD; MEDICAL AND PHARMACEUTICAL RESEARCH SERVICES; AND LABORATORY RELATED RESEARCH IN THE FIELD OF LIFE SCIENCES

Owner

• XSIRA PHARMACEUTICALS, INC., MORRISVILLE, NC, US
• XSIRA PHARMACEUTICALS, INC., MORRISVILLE, NC, US
• Norak Biosciences, Inc., Morrisville, NC, US

Prosecution history

• 06 Feb 2007 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
• 06 Feb 2007 — ABANDONMENT - NO USE STATEMENT FILED
• 06 Jun 2006 — NOA MAILED - SOU REQUIRED FROM APPLICANT
• 05 Apr 2006 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
• 14 Mar 2006 — PUBLISHED FOR OPPOSITION
• 22 Feb 2006 — NOTICE OF PUBLICATION
• 02 Feb 2006 — LAW OFFICE PUBLICATION REVIEW COMPLETED
• 31 Jan 2006 — ASSIGNED TO LIE
• 05 Dec 2005 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 03 Dec 2005 — AMENDMENT FROM APPLICANT ENTERED
• 15 Nov 2005 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 15 Nov 2005 — PAPER RECEIVED
• 20 May 2005 — NON-FINAL ACTION E-MAILED
• 20 May 2005 — NON-FINAL ACTION WRITTEN
• 20 May 2005 — ASSIGNED TO EXAMINER